仙琚制药(002332.SZ)：雌二醇片/雌二醇地屈孕酮片复合包装药品注册申请获得受理

Core Viewpoint - The company, Xianju Pharmaceutical, has received a production registration acceptance notice from the National Medical Products Administration for its combined packaging of estradiol tablets and estradiol-dydrogesterone tablets, indicating progress in its product development and regulatory approval process [1] Group 1 - The company has announced the receipt of a production registration acceptance notice for estradiol tablets and estradiol-dydrogesterone tablets [1] - The combined packaging specifications submitted by the company are consistent with those of the original research products that have already been approved for market [1] - The application is classified under Category 4 of chemical drugs [1]